Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / GT Medical Technologies, Inc.

GT Medical Technologies, Inc.

Series D+Tempe, AZOther Health Care
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
$100Msum of rounds with a disclosed amount only
Named investors
5
Financing history
2 rounds
  1. Jun 9, 2026
    Series E · $100M (disclosed)
    MVM Partners LLP (participant)Gilde Healthcare (participant)Evidity Capital LLC (participant)Medtech Venture Partners (participant)Femhealth Ventures Management LLC (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “GT Medical Technologies Completes Oversubscribed $100 Million Series E Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors”
  2. Dec 23, 2024
    Form D equity offering · $37.1M (form d sold) · 16 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “GT Medical Technologies, Inc. filed Form D: $37,100,907 sold of $43,505,901, Other Health Care”
Investors on record
6 edges
People
2 officers, 5 directors
Timeline
3
  1. Jun 9, 2026
    GT Medical Technologies announced Series E of $100,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  2. Jun 11, 2025
    GT Medical Technologies, Inc. filed Form D/A: $53,300,905 sold of $53,300,905, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Mar 3, 2025
    GT Medical Technologies, Inc. filed Form D: $37,100,907 sold of $43,505,901, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
31 observations
Every observation on this company